Prostate Cancer and Prostatic Diseases

Prostate Cancer and Prostatic Diseases is published by Springer Nature and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research and Urinary Bladder and Prostate Research, together about 65.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis. Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance. The following is a non-exhaustive list of the general topics covered by Prostate Cancer and Prostatic Diseases: Alternative therapies Angiogenesis Anti-sense oligonucleotides against growth factors Brachytherapy Conformal radiotherapy Conformal radiotherapy Cyclotron fast neutron treatment Enhancing the results of radical prostatectomy Epidemiology of prostate cancer and prostatic diseases Familial prostate cancer Free to total PSA Gene therapy for prostate cancer Genetic basis for prostate cancer Hormone-related disease How significant is PSA-detected disease? Intermittent antiandrogen therapy Mechanisms of tumour invasion in prostate cancer Medical and surgical therapies for male LUTS Medical therapy for male LUTS: the road ahead Natural history of prostate cancer and prostatic diseases Nutrition in prostate cancer and prostatic diseases Photodynamic therapy Prognostic markers Prostate cancer and potency and impotence Prostatic intra-epithelial neoplasia - an important precursor of cancer Prostatitis: quo vadis? Quality of life issues Racial issues in prostate cancer Recurrence after radical prostatectomy Reproducibility (test-retest reliability) of investigations for prostatic diseases Reverse transcriptase polymerase chain reaction to detect circulating mRNA for PSA Role of differentiation therapy Screening for prostate cancer Staging of prostate cancer: beyond conventional imaging The ma

From the journal's Aims & Scope

Research area (LetPub): Urology & Nephrology

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEEmbaseCurrent ContentsPublisher website

Other: Index Medicus

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

6.74LetPub · 2026-09-13

Impact factor (publisher) 2025

6.9Publisher website · 2026-09-29

5-year impact factor (publisher) 2025

5.6Publisher website · 2026-09-29

CiteScore 2026-06

11.9LetPub · 2026-09-13

SJR 2026-06

2.03LetPub · 2026-09-13

SNIP 2026-06

1.82LetPub · 2026-09-13

h-index

56LetPub · 2026-09-13

h-index

100OpenAlex · 2026-10-01

i10-index

1,505OpenAlex · 2026-10-01

2-year mean citedness

5.8OpenAlex · 2026-10-01

Self-citation rate

11.6%LetPub · 2026-09-13

Share of gold OA articles

34.08%LetPub · 2026-09-13

Volume

Articles per year

95LetPub · 2026-09-13

Downloads per year (publisher) 2025

1,374,753Publisher website · 2026-09-29

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

6–12 weeksLetPub · 2026-09-13

Average acceptance (community reports)

Fairly easyLetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Publisher

Springer Nature

Country or region

ENGLAND

Language

English

Frequency

Quarterly

Founded

1997

ISSN

1365-7852

Electronic ISSN

1476-5608

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗LetPub
• Author guidelines ↗LetPub
• Special issues ↗Publisher website